Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts.
about
FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1Sphingosine kinase and sphingosine 1-phosphate in the heart: a decade of progressThe differential effects of FTY720 on functional recovery and infarct size following myocardial ischaemia/reperfusion.Ischemia-reperfusion injury in strokeSphingosine kinase and sphingosine 1-phosphate in cardioprotection.Cardiomyocyte S1P1 receptor-mediated extracellular signal-related kinase signaling and desensitizationCharacterization and Expression of Sphingosine 1-Phosphate Receptors in Human and Rat Heart.High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate.Sphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?Sphingosine-1-phosphate signaling and the skin.S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart.Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites.Insulin protects apoptotic cardiomyocytes from hypoxia/reoxygenation injury through the sphingosine kinase/sphingosine 1-phosphate axis.A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning.Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.Sphingolipids in cardiovascular diseases and metabolic disordersAdult onset cardiac dilatation in a transgenic mouse line with Galβ1,3GalNAc α2,3-sialyltransferase II (ST3Gal-II) transgenes: a new model for dilated cardiomyopathy.A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection.Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia.Activation of SphK1 by K6PC-5 Inhibits Oxygen-Glucose Deprivation/Reoxygenation-Induced Myocardial Cell Death.Sphingolipids in cardiovascular and cerebrovascular systems: Pathological implications and potential therapeutic targets.HDL and its sphingosine-1-phosphate content in cardioprotection.High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: Role of STAT3 as part of the SAFE pathway.Implication of sphingosin-1-phosphate in cardiovascular regulation.Serum sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injury.Sphingolipid therapy in myocardial ischemia-reperfusion injury.Differential regulation of sphingosine kinases 1 and 2 in lung injury.Nuclear and mitochondrial signalling Akts in cardiomyocytesPrenatal cocaine exposure abolished ischemic preconditioning-induced protection in adult male rat hearts: role of PKCepsilon.Cardioprotection in ischemia/reperfusion injury: spotlight on sphingosine-1-phosphate and bradykinin signalling.Regulation of cardiac excitation and contraction by p21 activated kinase-1PKCε activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sproutingPhospholipase C activation is required for cardioprotection by ethanol consumption.Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue.Sphingosine kinase regulation and cardioprotection.Sphingosine protects aging hearts from ischemia/reperfusion injury: Superiority to sphingosine 1-phosphate and ischemic pre- and post-conditioning.Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.Sphingosine-1-phosphate receptor signalling in the heart.Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein.Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs.
P2860
Q24298835-491EA821-192D-4745-A6C5-0EA68FC628E8Q27001065-72D83117-C252-480E-8171-0A8027A299F8Q33613072-1748A941-A5CA-4F9C-A033-EAC20C004536Q33653045-11962C0F-24E5-4405-A77B-02F56F475E07Q33715344-BD753054-D6D7-4A47-B1B1-069F2B183B5CQ33715382-25AA16E9-C8A5-4D2E-A26B-C0196CE4E1B9Q33720344-B09B3C00-E201-4EB6-ACFC-792A2F71345BQ33727619-254A2A03-9181-4565-9800-6C29FF8D7A04Q33753317-31BBC6FA-F86C-4CEC-93EA-E5F5B4E0FC3FQ34585376-6CC0FE29-D0B0-4F62-9055-847756E667BDQ34979795-2FD216A7-0602-4E84-8010-DDBF5C964ACBQ35048357-15CBFA10-65AF-4BE8-B75D-98A603201F3FQ35069407-047CF4F4-87C3-471F-9DBE-7AD3B2917AD6Q35195850-0A997FEA-F633-4FAF-921B-76C0E73C613DQ35395763-50BD652D-BEB2-4F8E-ADA1-88331829714AQ35750931-651EC54B-34F6-4F9F-9711-135708A1ACF3Q35855973-FF722F0C-C9DB-4EAA-9259-9D098303A7B1Q36011190-C26F6B18-E02B-4730-8E64-EA399599438CQ36109455-F15FA65B-9C87-4278-9DA7-2E2F1F9E6D67Q36274429-4EA68795-4B1C-4D43-8634-D5750A7DF206Q36840840-007E878E-D16E-4992-99B2-28C40250175AQ36842504-7BF14BC5-6BFE-4748-9821-8F60E08F58B2Q36895483-0A2BC2E3-D6C4-4D32-A27D-E2D4419C3F4CQ36898368-A7DC8336-6DFC-41BC-86B6-3F9EB829E626Q36923715-E5BDACA7-511E-4408-B10D-A859ABE7265FQ36967504-96798C8F-8430-4EF9-8C64-C49DB989E979Q37162745-A144D4A8-7A23-4F2E-87E1-3B548CBFDA69Q37176193-6B848351-BAC5-4658-9A84-345B2D272AA6Q37200189-4C7BA1C4-145C-4E9F-A7DC-3C512757CA12Q37220195-3B870C35-C8FE-4727-9678-CCF09578AC45Q37259560-1B2B223D-CED0-4A45-88AE-3B2F5D154F1BQ37267378-23AE453C-5C7D-40FC-B373-28884AE7E888Q37284638-8D104ED3-C3D1-4381-8454-C0ED80D3AA7CQ37319985-9543D0F6-8E1B-4776-905E-F56FECE251C4Q37328806-653B4691-B1BD-479F-BC87-C493E4C7BF99Q37390273-AD5E4AE9-8ABD-4F45-845A-F2D88A351DFCQ37406283-9E557659-C8C7-4973-ABB9-36D63DB93494Q37413862-38099CDE-D5B7-4497-88A9-4247197C2F6AQ37871354-F9EC450E-571A-4CAB-B2DE-B382297C56D9Q37950457-2DF6F823-2C16-4E2C-B801-13243D70648F
P2860
Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Cardioprotection mediated by s ...... epsilon knockout mouse hearts.
@en
Cardioprotection mediated by s ...... epsilon knockout mouse hearts.
@nl
type
label
Cardioprotection mediated by s ...... epsilon knockout mouse hearts.
@en
Cardioprotection mediated by s ...... epsilon knockout mouse hearts.
@nl
prefLabel
Cardioprotection mediated by s ...... epsilon knockout mouse hearts.
@en
Cardioprotection mediated by s ...... epsilon knockout mouse hearts.
@nl
P2093
P2860
P1476
Cardioprotection mediated by s ...... epsilon knockout mouse hearts.
@en
P2093
Edward J Goetzl
Hui-Zhong Zhou
Joel S Karliner
Mary O Gray
Norman Honbo
Robert O Messing
Zhu-Qiu Jin
P2860
P304
P356
10.1152/AJPHEART.01029.2001
P577
2002-06-01T00:00:00Z